Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Jasnita Telekomindo Tbk (JAST) vs UBC Medical Indonesia Tbk. (LABS) Price & Performance

Jasnita Telekomindo TbkTrade
UBC Medical Indonesia Tbk.Trade

Price performance (Past 24H)

Key statistics

Jasnita Telekomindo Tbk vs UBC Medical Indonesia Tbk. — how do they compare? Jasnita Telekomindo Tbk trades at Rp85 (market cap 93.1B, 13.56M 24h volume), while UBC Medical Indonesia Tbk. trades at Rp148 (market cap 576.7B, 3.48M 24h volume). The key difference: UBC Medical Indonesia Tbk. is far larger — about 6.2× Jasnita Telekomindo Tbk's market cap, and Jasnita Telekomindo Tbk is more actively traded (13.56M versus 3.48M). Which is the better fit depends on your goals.

JASTLABS
Market Cap
93.1B576.7B
Volume
13.56M3.48M
Lot
135.58K34.82K
Turnover
1.17B522.79M
Average Price
86.37150.13
Value
1.17B522.79M
Indicative Equilibrium Price
85148
Indicative Equilibrium Volume
907350

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

JAST
View details
LABS
View details

About Jasnita Telekomindo Tbk

PT Jasnita Telekomindo Tbk ("Company") was established in January 25,1996 based on the Deed of Establishment No. 119 dated January 25, 1996 which made before Agus Madjid, S.H., Notary in Jakarta which was later amended by the Amendment Act Articles of Association No. 45 dated August 14, 1996 made before Susi Susilowaty Wisnu, S.H., Substitute Notary from Agus Madjid, S.H., Notary in Jakarta.

Read more on JAST

About UBC Medical Indonesia Tbk.

PT UBC Medical Indonesia (the Company) was established under the framework of Law of the Republic of Indonesia No. 20 year 1994 concerning the Foreign Capital Investment, as amended by Law No. 25 year 2007 concerning the Capital Investment based on Notarial Deed No. 01 dated 4 June 2014 of Novita Puspitarini, S.H., Notary in Jakarta. The Company started its commercial activities in October 2014. The parent entity as well as the ultimate parent entity of the Company is PT Optel Investama Mulia.

Read more on LABS